What are the most effective strategies to improve adherence to asthma medication in non-adherent patients with asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To improve adherence to asthma medication, researchers should prioritize developing personalized intervention strategies that incorporate electronic monitoring techniques, as highlighted in the most recent study 1, to address the multifaceted nature of non-adherence. Current research lacks high-quality evidence on effective methods to improve medication adherence in asthma patients across different age groups. Future studies should incorporate longer follow-up periods beyond the typical short-term assessments to determine the sustainability of adherence improvements. Researchers should also move beyond self-reported adherence measures by implementing objective assessment tools such as electronic monitoring devices, pharmacy refill data, and biomarkers to accurately quantify medication use, as suggested by 1. Additionally, studies should examine the cost-effectiveness of various adherence interventions to guide healthcare resource allocation decisions, considering the findings of 1 that reducing dosage demands is an effective approach to enhancing medication adherence. Research should explore how digital health technologies, including smartphone apps and remote monitoring, can support adherence while investigating the impact of healthcare provider communication styles and shared decision-making on patient compliance, as recommended by 1. Finally, studies should address how socioeconomic factors, health literacy, and cultural beliefs influence adherence patterns, with particular attention to underrepresented populations who often face greater barriers to medication adherence. Some key areas to focus on include:

  • Developing personalized intervention strategies that address the multifaceted nature of non-adherence
  • Incorporating electronic monitoring techniques to accurately quantify medication use
  • Examining the cost-effectiveness of various adherence interventions
  • Exploring the impact of digital health technologies on adherence
  • Investigating the influence of socioeconomic factors, health literacy, and cultural beliefs on adherence patterns. By prioritizing these areas, researchers can work towards improving adherence to asthma medication and ultimately reducing morbidity, mortality, and improving quality of life for patients with asthma, as emphasized by 1.

From the Research

Gaps in Literature

The current literature on improving adherence to asthma medication has several gaps that need to be addressed:

  • Lack of high-quality evidence on methods to improve adherence to asthma medicines 2, 3, 4
  • Limited studies with prolonged follow-up periods to assess the long-term effectiveness of adherence strategies 2
  • Insufficient use of objective measures to assess adherence, with many studies relying on self-reported measures 2, 3
  • Need for more research on the clinical and cost-effectiveness of different adherence strategies in adults, young people, and children with asthma 5, 6

Areas for Further Research

To fill the gaps in literature, further research is needed in the following areas:

  • Development and evaluation of innovative adherence strategies, such as mobile health applications or personalized medication plans 2, 3
  • Investigation of the factors influencing adherence to asthma medication, including patient-related, healthcare-related, and socio-economic factors 4, 5
  • Assessment of the cost-effectiveness of different adherence strategies, including pharmacoeconomic analyses and cost-utility studies 6
  • Examination of the impact of adherence strategies on health-related quality of life and patient-centered outcomes in adults, young people, and children with asthma 5, 6

Methodological Limitations

The current literature is also limited by methodological flaws, including:

  • Small sample sizes and short follow-up periods, which can lead to biased estimates of adherence and treatment effects 2, 3
  • Lack of control groups or comparator arms, making it difficult to evaluate the effectiveness of adherence strategies 4
  • Inadequate adjustment for confounding variables, which can lead to biased estimates of treatment effects 5, 6

Related Questions

What are the considerations for a patient with asthma experiencing persistent nocturnal cough and wheezing?
What is the diagnosis and treatment for a 10-year-old patient presenting with exercise-induced asthma (EIA) symptoms during the initial visit?
What is the recommended treatment approach for asthma management?
What are the alternatives to Montelukast (Singulair) for patients with severe depressive disorder?
What are the alternatives to Pulmicort (Budesonide)?
What are the brand names of the most commonly prescribed 100 pharmaceuticals (medications) in the United States of America (USA)?
What are the next steps in managing a 67-year-old white male with a history of Polymyalgia Rheumatica (PMR), skin Cancer (CA), Thoracic Aortic Aneurysm (TAA), Osteoarthritis (OA), lymphocytic colitis, erosive gastropathy, and kidney cyst, found to have a dilated thoracic ascending aorta measuring 4.3 cm?
What oral medication can be used to treat a 56-year-old male with bilateral bacterial conjunctivitis and discharges that is not improving with ofloxacin (fluorquinolone antibiotic)?
What type of shock does a patient with hypotension, tachycardia, and impaired consciousness present, given an Intracardiac pressure (IC) of 1.7, Pulmonary Capillary Wedge Pressure (PCWP) of 22 mmHg, and Systemic Vascular Resistance (SVR) of 1000 dynes/second?
What is the treatment for Erysipelas (Erythema infectiosum)?
What is the diagnosis for a patient with polytrauma, quadriplegia due to a C3 fracture, presenting with tachycardia and hypotension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.